RaySearch and Eckert & Ziegler BEBIG sign partnership agreement regarding brachytherapy

RaySearch and Eckert & Ziegler BEBIG, a leading European supplier of brachytherapy products, have signed a partnership agreement. Both the RayStation® treatment planning system and the RayCare oncology information system will be integrated with the Eckert & Ziegler BEBIG brachytherapy systems.

This will allow Eckert & Ziegler BEBIG to offer a complete brachytherapy solution, including treatment devices, treatment planning and oncology information management. The cooperation is in line with RaySearch’s aim to support as many treatment systems and approaches as possible.

Brachytherapy is a radiation therapy technique in which a small radioactive implant is inserted into the patient’s tissue, directly into the tumor or close to it. The implant may be temporary or permanent. Using implants makes it possible to deliver a higher dose of radiation to a smaller area than may possible with other forms of radiation therapy, thus minimizing damage to surrounding tissue and organs. Brachytherapy is most commonly used in treating prostate cancer but can be applied to many other areas, including cancers of the brain, eye, lung and skin.

Dr. Harald Hasselmann, CEO of Eckert & Ziegler BEBIG, says:

We are very happy about the partnership with RaySearch, which promises a pathway to better integration of brachytherapy into modern radiation therapy workflows. Brachytherapy can significantly improve treatment outcome, either as a single treatment method or in combination with other therapies. Integration is key for future optimization, and this partnership is an important step forward.”

Johan Löf, CEO of RaySearch, says:

It is exciting to enter into this new treatment area for RayStation and RayCare. Brachytherapy is a highly accurate technique, and the capabilities of our software will bring a new dimension to treatment. We have an excellent partner in Eckert & Ziegler BEBIG, a leading brachytherapy innovator with an excellent product portfolio, and I look forward to a successful collaboration.”

Source: https://www.raysearchlabs.com/media/press/?year=2018&cisionid=2980978

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    RaySearch Laboratories AB. (2018, July 04). RaySearch and Eckert & Ziegler BEBIG sign partnership agreement regarding brachytherapy. News-Medical. Retrieved on April 25, 2024 from https://www.news-medical.net/news/20180704/RaySearch-and-Eckert-Ziegler-BEBIG-sign-partnership-agreement-regarding-brachytherapy.aspx.

  • MLA

    RaySearch Laboratories AB. "RaySearch and Eckert & Ziegler BEBIG sign partnership agreement regarding brachytherapy". News-Medical. 25 April 2024. <https://www.news-medical.net/news/20180704/RaySearch-and-Eckert-Ziegler-BEBIG-sign-partnership-agreement-regarding-brachytherapy.aspx>.

  • Chicago

    RaySearch Laboratories AB. "RaySearch and Eckert & Ziegler BEBIG sign partnership agreement regarding brachytherapy". News-Medical. https://www.news-medical.net/news/20180704/RaySearch-and-Eckert-Ziegler-BEBIG-sign-partnership-agreement-regarding-brachytherapy.aspx. (accessed April 25, 2024).

  • Harvard

    RaySearch Laboratories AB. 2018. RaySearch and Eckert & Ziegler BEBIG sign partnership agreement regarding brachytherapy. News-Medical, viewed 25 April 2024, https://www.news-medical.net/news/20180704/RaySearch-and-Eckert-Ziegler-BEBIG-sign-partnership-agreement-regarding-brachytherapy.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
MD Anderson and RaySearch partner to enhance cancer radiation therapy